Skip to main content
. 2021 Jan 22;36(8):2337–2348. doi: 10.1007/s00467-021-04928-w

Table 4.

Unadjusted and adjusted KRT patient survival probabilities

Period Unadjusted patient survival probability (95% CI) Adjusted patient survival probability (95% CI)
1 year 2 years 5 years 1 year 2 years 5 years
2007 97.2 (95.7–98.7) 95.7 (93.9–97.6) 94.1 (92.0–96.3) 98.1 (96.9–99.3) 96.7 (95.4–98.6) 95.8 (93.9–97.9)
2008 96.7 (95.0–98.3) 95.8 (93.9–97.6) 93.4 (91.1–95.7) 97.5 (96.1–98.9) 96.8 (95.2–98.4) 94.9 (92.8–97.1)
2009 97.0 (95.5–98.6) 95.5 (93.6–97.4) 94.2 (92.1–96.3) 97.5 (96.1–98.9) 96.5 (94.8–98.2) 95.4 (93.4–97.5)
2010 96.3 (94.4–98.1) 95.3 (93.2–97.4) 93.7 (91.4–96.1) 98.6 (97.4–99.7) 98.2 (96.8–99.6) 97.5 (95.8–99.3)
2011 98.2 (96.9–99.5) 96.1 (94.2–98.1) 93.4 (91.5–96.4) 98.4 (97.2–99.6) 96.5 (94.7–98.5) 94.6 (92.2–97.1)
2012 96.6 (94.4–98.0) 95.0 (93.0–97.1) 97.1 (95.5–98.7) 96.2 (94.4–98.1)
2013 97.7 (96.2–99.1) 96.7 (95.3–98.6) 99.4 (98.5–100) 99.2 (98.3–100)
2014 98.5 (97.4–99.6) 97.7 (96.3–99.0) 99.9 (88.2–100) 99.9 (82.7–100)
2015 99.6 (99.0–100) 99.8 (84.9–100)
2007–2016 97.6 (97.1–98.1) 96.4 (95.8–96.9) 94.4 (93.6–95.2) 98.2 (97.8–98.6) 97.3 (96.8–97.8) 95.8 (95.0–96.5)

*Adjusted for fixed values for age at KRT (8.5 years), male sex (59%), glomerulonephritis (15%), CAKUT (38%), hereditary nephropathy (12%), and cystic kidney disease (7%)